Education
About Us
Working with TipRanks
Follow Us
Senzime AB (SE:SEZI)
:SEZI
SEZI Stock Chart & Stats
kr5.13
-kr0.14(-2.60%)
At close: 4:00 PM EST
kr5.13
-kr0.14(-2.60%)
Day’s Range― - ―
52-Week Rangekr3.60 - kr7.38
Previous CloseN/A
Volume45.51K
Average Volume (3M)534.13K
Market Cap
kr768.78M
Enterprise Valuekr721.20M
Total Cash (Recent Filing)kr73.97M
Total Debt (Recent Filing)kr26.40M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Apr 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding157,215,040
10 Day Avg. Volume328,516
30 Day Avg. Volume534,125
Financial Highlights & Ratios
PEG Ratio1.40
Price to Book (P/B)2.61
Price to Sales (P/S)7.63
P/FCF Ratio-7.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.2
Revenue Forecast (FY)kr191.30M
Bulls Say, Bears Say
Bulls Say
Revenue & Gross Margin ImprovementSenzime delivered a material step-up in top-line growth alongside a return to positive gross margins in 2025. Sustained revenue expansion plus healthier gross margins improves the firm’s ability to scale fixed costs, enabling operating leverage if sales momentum and disposables attach rates persist.
NextGen Adoption Driving Recurring ConsumablesStrong NextGen adoption produced >50% utilization uplifts at upgraded accounts, creating durable revenue from recurring sensors and monitoring accessories. Higher usage per install increases customer stickiness and predictable consumable-driven revenue over multiple years.
Liquidity Support Via Credit FacilityThe SEK 50m credit facility provides near-term liquidity and reduces immediate pressure to raise equity. Coupled with in-house monitor capacity and a sizeable equity base, the facility materially lowers refinancing risk over the next 6–12 months while supporting rollout and inventory transitions.
Bears Say
Persistent Negative Free Cash FlowFree cash flow remains deeply negative and tracked net losses in 2025, indicating losses are translating into cash burn rather than being absorbed by non-cash items. Continued heavy cash outflows increase the likelihood of future financing, dilutive capital raises, or constrained investment flexibility.
Very Negative Operating And Net MarginsDespite revenue growth and gross margin gains, operating and net margins remain highly negative, showing fixed and operating costs exceed current scale. Without clear evidence of sustained margin compression, profitability risk persists and could impair free cash flow recovery even if revenue rises.
Placement Model Increases Near-term Capital NeedsShifting to a placement/service model accelerates adoption but requires the company to fund instruments and bear upfront CapEx and working capital. This structural increase in capital intensity magnifies liquidity and execution risk while cash burn remains elevated and regulatory timing can delay payback.
Senzime AB News
SEZI FAQ
What was Senzime AB’s price range in the past 12 months?
Senzime AB lowest stock price was kr3.60 and its highest was kr7.38 in the past 12 months.
What is Senzime AB’s market cap?
Senzime AB’s market cap is kr768.78M.
When is Senzime AB’s upcoming earnings report date?
Senzime AB’s upcoming earnings report date is Apr 22, 2026 which is in 47 days.
How were Senzime AB’s earnings last quarter?
Senzime AB released its earnings results on Feb 18, 2026. The company reported -kr0.273 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.273.
Is Senzime AB overvalued?
According to Wall Street analysts Senzime AB’s price is currently Overvalued.
Does Senzime AB pay dividends?
Senzime AB does not currently pay dividends.
What is Senzime AB’s EPS estimate?
Senzime AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Senzime AB have?
Senzime AB has 157,215,040 shares outstanding.
What happened to Senzime AB’s price movement after its last earnings report?
Senzime AB reported an EPS of -kr0.273 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.494%.
Which hedge fund is a major shareholder of Senzime AB?
Currently, no hedge funds are holding shares in SE:SEZI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Senzime AB
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.
SEZI Company Deck
SEZI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents solid commercial momentum—notably strong NextGen adoption with >50% usage uplifts, geographic expansion, a SEK 50m credit facility, and a new service business model that shortens sales cycles and should improve long‑term margins. Headwinds are primarily timing and external: FX weakness reduced reported top‑line versus guidance, regulatory delays (notably Korea) postponed some revenues, and there were Q4 one‑off costs plus an inventory write‑down as the company phases out the Classic product. Management expects lower operating expenses in 2026 and to reach cash‑flow positivity in Q4 2026, indicating confidence in recovery of near‑term issues.View all SE:SEZI earnings summariesTechnical Analysis
Bactiguard Holding AB
―
C-Rad AB Class B
―
Integrum AB Class B
―
Sedana Medical AB
―
OssDsign AB
―